TIPRL and gastric cancer: TIPRL also promoted AMP-activated protein kinase (AMPK) activation, which in turn reduced phosphorylation of mTOR, 4EBP-1, and S6K, resulting in mTOR signaling deactivation and consequent inhibition of tumor invasion in GC (Luan et al., 2020).